Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
Authors:
Open Access
- 30 November 2021
- journal article
- editorial
- Published by Korean Diabetes Association in Diabetes & Metabolism Journal
- Vol. 45 (6) , 972-973
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver DiseaseDiabetes & Metabolism Journal, 2021
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 updateJournal of Hepatology, 2021
- Nonalcoholic Fatty Liver Disease and Recent Guideline UpdatesClinical Liver Disease, 2021
- Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease: A Korean Diabetes Association and Korean Society of Nephrology Consensus StatementDiabetes & Metabolism Journal, 2020
- Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetesJournal of Hepatology, 2018
- Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort StudyPLOS Medicine, 2016
- Combined application of eGFR and albuminuria for the precise diagnosis of stage 2 and 3a CKD in the elderlyJournal Of Nephrology, 2014